Risk Factors and Gene Type for Infections of MRSA in Diabetic Foot Patients in Tianjin, China

被引:29
|
作者
Feng, Shu-Hong [1 ,2 ]
Chu, Yue-Jie [1 ,2 ]
Wang, Peng-Hua [1 ,2 ]
Jun, Xu [1 ,2 ]
Min, Ding [1 ,2 ]
Li, Xue-Mei [1 ,2 ]
机构
[1] Tianjin Med Univ, Collaborat Innovat Ctr Tianjin Med Epigenet 2011, Key Lab Hormones & Dev, Metab Dis Hosp,Minist Hlth,Dept Diabet Foot, Tianjin 300070, Peoples R China
[2] Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin 300070, Peoples R China
来源
INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS | 2013年 / 12卷 / 02期
关键词
diabetic foot infections; methicillin-resistant Staphylococcus aureus; methicillin-susceptible Staphylococcus aureus; risk factors; gene type; RESISTANT STAPHYLOCOCCUS-AUREUS; STRAINS; IDENTIFICATION; COMMUNITY; ULCERS;
D O I
10.1177/1534734613489991
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The objective was to study risk factors and gene type of DF patients infected with MRSA. A total of 429 DF patients were recruited. The patients with S aureus infections were divided into MRSA and MSSA groups. MRSA were genotyped by SCCmec. pvl and lukE-lukD were detected. A total of 559 pathogens were isolated from them, with G(+) bacteria firstly(59.0%), followed G-bacilli (37.7%) and true fungi (3.3%). The 3 most frequently isolated pathogens were S aureus (35.2%), S epidermidis (12.3%), and Pseudomonas aeruginosa (11.2%). SCCmec III MRSA and SCCmec IVa MRSA had the same antibacterial spectrum. mecA positive rate was 100%. lukE-lukD and pvl positive rates were 100% and 0%, respectively. 28 strains belonged to SCCmec III and the others belonged to SCCmec IVa. The G(+) cocci were the main pathogens, S aureus and S epidermidis were predominant among them. Antibiotic usage in 6 months prior to hospitalization, long course of ulcer, osteomyelitis and hypoproteinemia are risk factors for MRSA. SCCmec IVa is high in proportion to MRSA isolates, suggesting that CA-MRSA has become major pathogen of DF infection. All the MRSA were harboring lukE-lukD, which has been reported to present poor leucotoxin compared to pvl, and may be a response to atypical local inflammatory reaction in DF infection.
引用
收藏
页码:106 / 112
页数:7
相关论文
共 50 条
  • [1] Frequency of MRSA in diabetic foot infections
    Akhi, Mohammad Taghi
    Ghotaslou, Reza
    Memar, Mohammad Yousef
    Asgharzadeh, Mohammad
    Varshochi, Mojtaba
    Pirzadeh, Tahereh
    Alizadeh, Naser
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2017, 37 (01) : 58 - 62
  • [2] Frequency of MRSA in diabetic foot infections
    Mohammad Taghi Akhi
    Reza Ghotaslou
    Mohammad Yousef Memar
    Mohammad Asgharzadeh
    Mojtaba Varshochi
    Tahereh Pirzadeh
    Naser Alizadeh
    International Journal of Diabetes in Developing Countries, 2017, 37 : 58 - 62
  • [3] Risk factors for diabetic foot development in type II diabetic patients
    Pankiv, VI
    Tronko, ND
    Efimov, AS
    Kravchenko, VI
    DIABETOLOGIA, 1997, 40 : 1849 - 1849
  • [4] Diabetic foot risk factors in diabetes type 1 patients
    Nehring, Piotr
    Mrozikiewicz-Rakowska, Beata
    Sobczyk-Kopciol, Agnieszka
    Karnafel, Waldemar
    CLINICAL DIABETOLOGY, 2013, 2 (05): : 160 - 164
  • [5] Evaluation of mortality risk factors in diabetic foot infections
    Sen, Pinar
    Demirdal, Tuna
    INTERNATIONAL WOUND JOURNAL, 2020, 17 (04) : 880 - 889
  • [6] RISK FACTORS ASSOCIATED WITH 30 DAY READMISSION IN PATIENTS WITH DIABETIC FOOT INFECTIONS
    Miller, Marshall
    Young, Heather
    Knepper, Bryan
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 : S310 - S310
  • [7] Risk factors for mortality in patients with diabetic foot infections: a prospective cohort study
    Lynar, Sarah A.
    Robinson, Claire H.
    Boutlis, Craig S.
    Commons, Robert J.
    INTERNAL MEDICINE JOURNAL, 2019, 49 (07) : 867 - 873
  • [8] Risk factors of the diabetic foot syndrome in patients with type 2 diabetes
    Ducka, Bernadeta
    Strojek, Krzysztof
    CLINICAL DIABETOLOGY, 2012, 1 (04): : 138 - 145
  • [9] Risk factors for diabetic foot among diabetic patients
    Ninan, E. T.
    Vasudevan, B.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2008, 127 (06) : 677 - 677
  • [10] Parenteral Vancomycin in the Treatment of MRSA-Associated Diabetic Foot Infections: An Unnecessary Risk
    Joseph, Warren S.
    Kosinski, Mark A.
    Rogers, Lee C.
    INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, 2023,